Gamida Cell Ltd

General ticker "GMDA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $50.0M

Gamida Cell Ltd does not follow the US Stock Market performance with the rate: -35.0%.

Estimated limits based on current volatility of 7.3%: low 0.01$, high 0.02$

Factors to consider:

  • Earnings expected soon, date: 2024-05-20
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term predictions were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 predicted range: [1.03$, 2.34$]
  • 2023-12-31 to 2024-12-30 predicted range: [1.13$, 2.49$]

Financial Metrics affecting the GMDA estimates:

  • Negative: Non-GAAP EPS of -1.23 <= 0.09
  • Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
  • Negative: Operating Cash Flow per share of -1.10 <= 0.22
  • Negative: negative Net Income
  • Negative: Industry Operating Cash Flow per share (median) of -1.67 <= 0.29
  • Negative: Industry Operating Income to Revenue ratio (median) of -0.98 <= 0.02

Similar symbols

Short-term GMDA quotes

Long-term GMDA plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $60.92MM $87.17MM $74.99MM
Operating Income $-60.92MM $-87.17MM $-74.99MM
Non-Operating Income $-0.65MM $-2.63MM $-4.38MM
Interest Expense $10.64MM $2.63MM $4.38MM
R&D Expense $41.38MM $50.18MM $42.69MM
Income(Loss) $-61.57MM $-89.79MM $-79.38MM
Profit(Loss) $-61.57MM $-89.79MM $-79.38MM
Stockholders Equity $98.74MM $43.94MM $-8.02MM
Assets $155.48MM $148.79MM $124.77MM
Operating Cash Flow $-50.22MM $-81.76MM $-70.42MM
Investing Cash Flow $1.59MM $-60.92MM $34.04MM
Financing Cash Flow $133.96MM $71.40MM $45.14MM
Earnings Per Share* $-1.75 $-1.56 $-2.42

* EPS are Split Adjusted, recent splits may be reflected with a delay.